Katalyze AI builds an agentic operating system for the pharmaceutical industry, integrating lab and plant systems to unify fragmented production data and provide a traceable, GxP-native foundation for AI agents. The platform enables deployment of domain-trained autonomous agents to automate complex engineering, scientific, and manufacturing workflows for biopharma companies.
Key Executives
Katalyze AI LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Katalyze AI had 48 employees as of October 12, 2026. The number of employees decreased by 1 (2.04%) week-over-week.
Katalyze AI had 3,790 followers as of October 12, 2026. The number of followers increased by 57 (1.53%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 13, 2026 | Seed Round | $10.50M | ― |
| Investor Name | Funding Round |
|---|---|
| Bonfire Ventures | Seed Round |
| Inovia Capital | Seed Round |
| Ripple Ventures | Seed Round |
| Alumni Ventures | Seed Round |
| Gokul Rajaram | Seed Round |
| Farzad Soleimani | Seed Round |
A snapshot of private companies similar to Katalyze AI, helping you discover and navigate related company profiles.